Presentation TCT 2012 State-of-the-Field Keynote: Technical and Biological Challenges for Future DCB Development Presenter: Juan Granada October 23, 2012
Presentation TCT 2012 Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA Presenter: Patrick Calvert October 23, 2012
Presentation TCT 2012 TCT-24. Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment of Coronary Plaque Burden and Lipid Pools: Validation with Histology Presenter: Rishi Puri October 23, 2012
Presentation TCT 2012 TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial Presenter: Gregg Stone October 23, 2012
Presentation TCT 2012 TCT-56. Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding Events After Percutaneous Coronary Intervention Presenter: Fabio Mangiacapra October 23, 2012
Presentation TCT 2012 Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Con! Presenter: Alex Powell October 23, 2012
Presentation TCT 2012 VESTAsync (MIV Therapeutics) Program Update Presenter: Ricardo Costa October 23, 2012
Presentation TCT 2012 Synthesis of the New ESC LAA Closure Guidelines Presenter: Peter Sick October 23, 2012
Presentation TCT 2012 TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention Presenter: Tim van de Hoef October 23, 2012
Presentation TCT 2012 Nanoparticle-Based Stents 2: FOCUS np (Envision Scientific) Program Update Presenter: Ashok Seth October 23, 2012